Bristol-Myers: Walking Blindfolded To A $30 Billion Patent Cliff

Myers' upcoming $30B patent cliff as the Growth portfolio lost significant potential. Read why BMY stock is downgraded to ...

Eli Lilly's Experimental Cancer Drug Cuts Recurrence Risk In Early-Stage Lung Cancer Patients

Eli Lilly and Co. LLY on Monday shared positive topline results from the Phase 3 LIBRETTO-432 clinical trial for Retevmo ...

Eli Lilly Just Delivered Great News for Investors -- and It Goes Beyond Weight-Loss Drugs

Eli Lilly isn't a one-trick pony.

Did Eli Lilly Just Make a Deal for Its Next Blockbuster Drug?

Eli Lilly announced an acquisition of an innovative new autoimmune drug.
24/7 Wall St.

Why Eli Lilly’s $1 Billion AI Bet Could Reshape Drug Discovery

A prior version of this article stated Eli Lilly and Nvidia had funded a supercomputer, when the commitment was for the co-innovation lab. This article has been updated to reflect the change. If there ...
CNBC

CNBC Select’s weekly mortgage rate snapshot: See your options today

The average 30-year fixed-rate mortgage is continuing to hover in the low 6.0% range. The U.S. 30-year fixed mortgage rate averaged 6.09% during the week ending on Feb. 12, according to the latest ...